An integrative multi-omics approach in Sjögren’s Syndrome identifies novel genetic drivers with regulatory function and disease-specificity
María Teruel, Guillermo Barturen, Manuel Martínez-Bueno, Miguel Barroso, Olivia Castelli, Elena Povedano, Martin Kerick, Francesc Català-Moll, Zuzanna Makowska, Anne Buttgereit, PRECISESADS Clinical Consortium, PRECISESADS Flow Cytometry Study Group, Jacques-Olivier Pers, Concepción Marañón, Esteban Ballestar, Javier Martin, View ORCID ProfileElena Carnero-Montoro, Marta E. Alarcón-Riquelme
doi: https://doi.org/10.1101/2020.09.14.20192211
María Teruel
1GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain
Guillermo Barturen
1GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain
Manuel Martínez-Bueno
1GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain
Miguel Barroso
1GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain
Olivia Castelli
1GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain
Elena Povedano
1GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain
Martin Kerick
2IBPLN- CSIC, Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas, Granada 18016, Spain
Francesc Català-Moll
3IDIBELL, Bellvitge Biomedical Research Institute 08907 L’Hospitalet de Llobregat, Barcelona, Spain
4Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916 Badalona, Barcelona, Spain
Zuzanna Makowska
5Pharmaceuticals Division, Bayer Pharma Aktiengesellschaft, Berlin, Germany
Anne Buttgereit
5Pharmaceuticals Division, Bayer Pharma Aktiengesellschaft, Berlin, Germany
Jacques-Olivier Pers
5Pharmaceuticals Division, Bayer Pharma Aktiengesellschaft, Berlin, Germany
Concepción Marañón
1GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain
Esteban Ballestar
3IDIBELL, Bellvitge Biomedical Research Institute 08907 L’Hospitalet de Llobregat, Barcelona, Spain
4Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916 Badalona, Barcelona, Spain
Javier Martin
2IBPLN- CSIC, Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas, Granada 18016, Spain
Elena Carnero-Montoro
1GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain
Marta E. Alarcón-Riquelme
1GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016 Granada, Spain
7Institute for Environmental Medicine, Karolinska Institutet, 171 67 Solna, Sweden
Article usage
Posted October 01, 2020.
An integrative multi-omics approach in Sjögren’s Syndrome identifies novel genetic drivers with regulatory function and disease-specificity
María Teruel, Guillermo Barturen, Manuel Martínez-Bueno, Miguel Barroso, Olivia Castelli, Elena Povedano, Martin Kerick, Francesc Català-Moll, Zuzanna Makowska, Anne Buttgereit, PRECISESADS Clinical Consortium, PRECISESADS Flow Cytometry Study Group, Jacques-Olivier Pers, Concepción Marañón, Esteban Ballestar, Javier Martin, Elena Carnero-Montoro, Marta E. Alarcón-Riquelme
medRxiv 2020.09.14.20192211; doi: https://doi.org/10.1101/2020.09.14.20192211
An integrative multi-omics approach in Sjögren’s Syndrome identifies novel genetic drivers with regulatory function and disease-specificity
María Teruel, Guillermo Barturen, Manuel Martínez-Bueno, Miguel Barroso, Olivia Castelli, Elena Povedano, Martin Kerick, Francesc Català-Moll, Zuzanna Makowska, Anne Buttgereit, PRECISESADS Clinical Consortium, PRECISESADS Flow Cytometry Study Group, Jacques-Olivier Pers, Concepción Marañón, Esteban Ballestar, Javier Martin, Elena Carnero-Montoro, Marta E. Alarcón-Riquelme
medRxiv 2020.09.14.20192211; doi: https://doi.org/10.1101/2020.09.14.20192211
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (710)
- Anesthesia (201)
- Cardiovascular Medicine (2946)
- Dermatology (249)
- Emergency Medicine (440)
- Epidemiology (12753)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4587)
- Geriatric Medicine (419)
- Health Economics (729)
- Health Informatics (2918)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (426)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4362)
- Nursing (236)
- Nutrition (639)
- Oncology (2271)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1197)
- Primary Care Research (496)
- Public and Global Health (6944)
- Radiology and Imaging (1529)
- Respiratory Medicine (915)
- Rheumatology (438)
- Sports Medicine (385)
- Surgery (489)
- Toxicology (60)
- Transplantation (212)
- Urology (181)